are there significant differences among the 1st and 2nd generation egfr tkis?
Published 8 years ago • 148 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
3:28
are there clinically significant differences among the third generation egfr inhibitors?
-
4:44
are there clinically significant differences among the second generation alk inhibitors?
-
2:22
are there distinctions among currently available oral egfr inhibitors?
-
1:59
what is egfr and the egfr mutation?
-
3:07
third generation egfr tkis for acquired resistance
-
![cancer is a myth [functional forum]](https://i.ytimg.com/vi/nZHwJLDPhsU/mqdefault.jpg)
15:40
cancer is a myth [functional forum]
-
4:08
what if osimertinib stops working? - 2022 program: targeted therapies forum
-
4:22
vegf and egfr pathways in detail: target for new therapies against cancer
-
5:22
egfr tkis and their side effects - 2022 program: targeted therapies forum
-
3:28
should third generation egfr inhibitors be used before or after progression?
-
1:01
dr. philip bonomi: gefitinib and later generations of egfr inhibitors
-
12:58
egfr inhibitor therapy in second line
-
1:39
2020 ttf egfr session qa panel what is the difference between c797s and c797x
-
1:50
2020 ttf alk/ros session qa panel the difference in efficacy of tkis in different patients
-
7:36
egfr tkis: efficacy, combinations, & use after chemotherapy - 2022 program: targeted therapies forum
-
2:01
should we use dna or rna for ngs? - 2022 program: targeted therapies forum
-
1:59
rna or dna: which ngs test to use - 2022 program: targeted therapies forum
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
2:21
should egfr tki therapy be continued beyond progression?
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum